{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 2936, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de072-45ef-70e3-98c4-13cdd518db84", "docSlug": "92694634ed4af010e4f3b01de2ec1b5f", "documentTitle": "AgroFresh | Results Presentation Deck | 16 slides", "authorId": "agrofresh", "authorName": "AgroFresh Solutions, Inc.", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7810761, "pageNumber": 4, "slideType": "key_messages", "function": "analyze_data", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-45ef-70e3-98c4-13cdd518db84/4", "deckHref": "/decks/019de072-45ef-70e3-98c4-13cdd518db84", "deckAnchorHref": "/decks/019de072-45ef-70e3-98c4-13cdd518db84#slide-4", "loopMatches": [ { "to": 10, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "8a62138d-cb37-45af-afec-eace2dad45eb", "evidence": "The KPI overview slides demonstrate the company's financial performance and growth.", "position": 0, "objective": "To show the importance of the company's solutions", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 8, "from": 4, "name": "So What Cascade", "slug": "41-so-what-cascade", "bestFor": "Data presentations, executive summaries, driving to recommendations", "matchId": "d5d4661c-6396-4974-8fe7-6b8aa9097333", "evidence": "The key messages and revenue breakdown slides illustrate the company's diversification strategy.", "position": 1, "objective": "To explain the significance of diversification", "structure": "The Data -> So What? (Insight 1) -> So What? (Insight 2) -> So What? (The Action)", "confidence": 0.6, "description": "Chain insights together, each answering 'so what?' until you reach the actionable conclusion" } ], "arcBeatMatches": [ { "to": 4, "from": 4, "beatId": "ae114958-72e7-4f12-88de-65653c9f5b0a", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "The key messages slide highlights the company's diversification strategy, which may spark interest in the audience.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-45ef-70e3-98c4-13cdd518db84", "docSlug": "92694634ed4af010e4f3b01de2ec1b5f", "documentTitle": "AgroFresh | Results Presentation Deck | 16 slides", "authorId": "agrofresh", "authorName": "AgroFresh Solutions, Inc.", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7810761, "pageNumber": 5, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a table-like structure to map product categories to specific performance drivers.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-45ef-70e3-98c4-13cdd518db84/5", "deckHref": "/decks/019de072-45ef-70e3-98c4-13cdd518db84", "deckAnchorHref": "/decks/019de072-45ef-70e3-98c4-13cdd518db84#slide-5", "loopMatches": [ { "to": 10, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "8a62138d-cb37-45af-afec-eace2dad45eb", "evidence": "The KPI overview slides demonstrate the company's financial performance and growth.", "position": 0, "objective": "To show the importance of the company's solutions", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 8, "from": 4, "name": "So What Cascade", "slug": "41-so-what-cascade", "bestFor": "Data presentations, executive summaries, driving to recommendations", "matchId": "d5d4661c-6396-4974-8fe7-6b8aa9097333", "evidence": "The key messages and revenue breakdown slides illustrate the company's diversification strategy.", "position": 1, "objective": "To explain the significance of diversification", "structure": "The Data -> So What? (Insight 1) -> So What? (Insight 2) -> So What? (The Action)", "confidence": 0.6, "description": "Chain insights together, each answering 'so what?' until you reach the actionable conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-45ef-70e3-98c4-13cdd518db84", "docSlug": "92694634ed4af010e4f3b01de2ec1b5f", "documentTitle": "AgroFresh | Results Presentation Deck | 16 slides", "authorId": "agrofresh", "authorName": "AgroFresh Solutions, Inc.", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7810761, "pageNumber": 6, "slideType": "before_after", "function": "analyze_data", "notes": "The slide uses a stacked bar chart for composition and a waterfall chart for growth attribution.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-45ef-70e3-98c4-13cdd518db84/6", "deckHref": "/decks/019de072-45ef-70e3-98c4-13cdd518db84", "deckAnchorHref": "/decks/019de072-45ef-70e3-98c4-13cdd518db84#slide-6", "loopMatches": [ { "to": 10, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "8a62138d-cb37-45af-afec-eace2dad45eb", "evidence": "The KPI overview slides demonstrate the company's financial performance and growth.", "position": 0, "objective": "To show the importance of the company's solutions", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 8, "from": 4, "name": "So What Cascade", "slug": "41-so-what-cascade", "bestFor": "Data presentations, executive summaries, driving to recommendations", "matchId": "d5d4661c-6396-4974-8fe7-6b8aa9097333", "evidence": "The key messages and revenue breakdown slides illustrate the company's diversification strategy.", "position": 1, "objective": "To explain the significance of diversification", "structure": "The Data -> So What? (Insight 1) -> So What? (Insight 2) -> So What? (The Action)", "confidence": 0.6, "description": "Chain insights together, each answering 'so what?' until you reach the actionable conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-45ef-70e3-98c4-13cdd518db84", "docSlug": "92694634ed4af010e4f3b01de2ec1b5f", "documentTitle": "AgroFresh | Results Presentation Deck | 16 slides", "authorId": "agrofresh", "authorName": "AgroFresh Solutions, Inc.", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7810761, "pageNumber": 7, "slideType": "revenue_buildup", "function": "show_valuation_bridge", "notes": "The slide uses a stacked bar chart for category mix and a waterfall bridge chart for growth analysis.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-45ef-70e3-98c4-13cdd518db84/7", "deckHref": "/decks/019de072-45ef-70e3-98c4-13cdd518db84", "deckAnchorHref": "/decks/019de072-45ef-70e3-98c4-13cdd518db84#slide-7", "loopMatches": [ { "to": 10, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "8a62138d-cb37-45af-afec-eace2dad45eb", "evidence": "The KPI overview slides demonstrate the company's financial performance and growth.", "position": 0, "objective": "To show the importance of the company's solutions", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 8, "from": 4, "name": "So What Cascade", "slug": "41-so-what-cascade", "bestFor": "Data presentations, executive summaries, driving to recommendations", "matchId": "d5d4661c-6396-4974-8fe7-6b8aa9097333", "evidence": "The key messages and revenue breakdown slides illustrate the company's diversification strategy.", "position": 1, "objective": "To explain the significance of diversification", "structure": "The Data -> So What? (Insight 1) -> So What? (Insight 2) -> So What? (The Action)", "confidence": 0.6, "description": "Chain insights together, each answering 'so what?' until you reach the actionable conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-45ef-70e3-98c4-13cdd518db84", "docSlug": "92694634ed4af010e4f3b01de2ec1b5f", "documentTitle": "AgroFresh | Results Presentation Deck | 16 slides", "authorId": "agrofresh", "authorName": "AgroFresh Solutions, Inc.", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7810761, "pageNumber": 8, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a table-like layout to categorize performance drivers by region.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-45ef-70e3-98c4-13cdd518db84/8", "deckHref": "/decks/019de072-45ef-70e3-98c4-13cdd518db84", "deckAnchorHref": "/decks/019de072-45ef-70e3-98c4-13cdd518db84#slide-8", "loopMatches": [ { "to": 10, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "8a62138d-cb37-45af-afec-eace2dad45eb", "evidence": "The KPI overview slides demonstrate the company's financial performance and growth.", "position": 0, "objective": "To show the importance of the company's solutions", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 8, "from": 4, "name": "So What Cascade", "slug": "41-so-what-cascade", "bestFor": "Data presentations, executive summaries, driving to recommendations", "matchId": "d5d4661c-6396-4974-8fe7-6b8aa9097333", "evidence": "The key messages and revenue breakdown slides illustrate the company's diversification strategy.", "position": 1, "objective": "To explain the significance of diversification", "structure": "The Data -> So What? (Insight 1) -> So What? (Insight 2) -> So What? (The Action)", "confidence": 0.6, "description": "Chain insights together, each answering 'so what?' until you reach the actionable conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-45ef-70e3-98c4-13cdd518db84", "docSlug": "92694634ed4af010e4f3b01de2ec1b5f", "documentTitle": "AgroFresh | Results Presentation Deck | 16 slides", "authorId": "agrofresh", "authorName": "AgroFresh Solutions, Inc.", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7810761, "pageNumber": 9, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The bridge chart illustrates the net change from $51.9M to $55.9M.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-45ef-70e3-98c4-13cdd518db84/9", "deckHref": "/decks/019de072-45ef-70e3-98c4-13cdd518db84", "deckAnchorHref": "/decks/019de072-45ef-70e3-98c4-13cdd518db84#slide-9", "loopMatches": [ { "to": 10, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "8a62138d-cb37-45af-afec-eace2dad45eb", "evidence": "The KPI overview slides demonstrate the company's financial performance and growth.", "position": 0, "objective": "To show the importance of the company's solutions", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-45ef-70e3-98c4-13cdd518db84", "docSlug": "92694634ed4af010e4f3b01de2ec1b5f", "documentTitle": "AgroFresh | Results Presentation Deck | 16 slides", "authorId": "agrofresh", "authorName": "AgroFresh Solutions, Inc.", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7810761, "pageNumber": 10, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a stacked bar chart for regional mix and a waterfall bridge chart for growth decomposition.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-45ef-70e3-98c4-13cdd518db84/10", "deckHref": "/decks/019de072-45ef-70e3-98c4-13cdd518db84", "deckAnchorHref": "/decks/019de072-45ef-70e3-98c4-13cdd518db84#slide-10", "loopMatches": [ { "to": 10, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "8a62138d-cb37-45af-afec-eace2dad45eb", "evidence": "The KPI overview slides demonstrate the company's financial performance and growth.", "position": 0, "objective": "To show the importance of the company's solutions", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-45ef-70e3-98c4-13cdd518db84", "docSlug": "92694634ed4af010e4f3b01de2ec1b5f", "documentTitle": "AgroFresh | Results Presentation Deck | 16 slides", "authorId": "agrofresh", "authorName": "AgroFresh Solutions, Inc.", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7810761, "pageNumber": 11, "slideType": "kpi_overview", "function": "analyze_data", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-45ef-70e3-98c4-13cdd518db84/11", "deckHref": "/decks/019de072-45ef-70e3-98c4-13cdd518db84", "deckAnchorHref": "/decks/019de072-45ef-70e3-98c4-13cdd518db84#slide-11", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-45ef-70e3-98c4-13cdd518db84", "docSlug": "92694634ed4af010e4f3b01de2ec1b5f", "documentTitle": "AgroFresh | Results Presentation Deck | 16 slides", "authorId": "agrofresh", "authorName": "AgroFresh Solutions, Inc.", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7810761, "pageNumber": 12, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes a bar chart showing Adjusted EBITDA trends and bulleted lists for financial highlights.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-45ef-70e3-98c4-13cdd518db84/12", "deckHref": "/decks/019de072-45ef-70e3-98c4-13cdd518db84", "deckAnchorHref": "/decks/019de072-45ef-70e3-98c4-13cdd518db84#slide-12", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-45ef-70e3-98c4-13cdd518db84", "docSlug": "92694634ed4af010e4f3b01de2ec1b5f", "documentTitle": "AgroFresh | Results Presentation Deck | 16 slides", "authorId": "agrofresh", "authorName": "AgroFresh Solutions, Inc.", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7810761, "pageNumber": 13, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes footnotes explaining specific financial adjustments and reconciliation references.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-45ef-70e3-98c4-13cdd518db84/13", "deckHref": "/decks/019de072-45ef-70e3-98c4-13cdd518db84", "deckAnchorHref": "/decks/019de072-45ef-70e3-98c4-13cdd518db84#slide-13", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-45ef-70e3-98c4-13cdd518db84", "docSlug": "92694634ed4af010e4f3b01de2ec1b5f", "documentTitle": "AgroFresh | Results Presentation Deck | 16 slides", "authorId": "agrofresh", "authorName": "AgroFresh Solutions, Inc.", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7810761, "pageNumber": 14, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-45ef-70e3-98c4-13cdd518db84/14", "deckHref": "/decks/019de072-45ef-70e3-98c4-13cdd518db84", "deckAnchorHref": "/decks/019de072-45ef-70e3-98c4-13cdd518db84#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 14, "beatId": "0ffc3e1c-c72b-4440-94ee-1ef39cc8f8da", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The executive summary slide provides a call to action for the audience to consider the company's results.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-45ef-70e3-98c4-13cdd518db84", "docSlug": "92694634ed4af010e4f3b01de2ec1b5f", "documentTitle": "AgroFresh | Results Presentation Deck | 16 slides", "authorId": "agrofresh", "authorName": "AgroFresh Solutions, Inc.", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7810761, "pageNumber": 15, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-45ef-70e3-98c4-13cdd518db84/15", "deckHref": "/decks/019de072-45ef-70e3-98c4-13cdd518db84", "deckAnchorHref": "/decks/019de072-45ef-70e3-98c4-13cdd518db84#slide-15", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-45ef-70e3-98c4-13cdd518db84", "docSlug": "92694634ed4af010e4f3b01de2ec1b5f", "documentTitle": "AgroFresh | Results Presentation Deck | 16 slides", "authorId": "agrofresh", "authorName": "AgroFresh Solutions, Inc.", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7810761, "pageNumber": 16, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes footnotes explaining specific adjustments and the methodology for constant currency calculations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-45ef-70e3-98c4-13cdd518db84/16", "deckHref": "/decks/019de072-45ef-70e3-98c4-13cdd518db84", "deckAnchorHref": "/decks/019de072-45ef-70e3-98c4-13cdd518db84#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 1, "slideType": "mission", "function": "inspire_vision", "notes": "The slide uses a global map background to imply the scale of the mission.", "imagePath": "https://imgproxy.kitesheet.com/tAoVspr6Qf3t7DpnFUbTxpr9pJZW103suSAGcDwvJVc/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80MGZkMTliNTEwNWVlZTc2ZmU4ZWRlZTIwMjUwZTEyYi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/1", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-1", "loopMatches": [ { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/6rGjdCSpuJ_eclEyBwt-P568mcn0px5jExFNt1twyMc/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80MGZkMTliNTEwNWVlZTc2ZmU4ZWRlZTIwMjUwZTEyYi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/30FPMXtAnfnNtSEDuy-xj3sdDwqUgP9sGzH7Hj2xi54/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80MGZkMTliNTEwNWVlZTc2ZmU4ZWRlZTIwMjUwZTEyYi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/8QxP0O-eDNNCvftmDIpA7Dd0iepL9JtbDDcMfYdEB8I/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80MGZkMTliNTEwNWVlZTc2ZmU4ZWRlZTIwMjUwZTEyYi9wMDAxLnBuZw" }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 2, "slideType": "appendix_disclosure", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/2", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-2", "loopMatches": [ { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 3, "slideType": "use_of_funds", "function": "plan_implementation", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/3", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-3", "loopMatches": [ { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 4, "slideType": "transition", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/4", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-4", "loopMatches": [ { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 5, "slideType": "team_bio", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/5", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-5", "loopMatches": [ { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 5, "from": 5, "beatId": "a53a2a93-bd71-41fd-9cba-719959051df0", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "Slide 5 presents the team", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 6, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a split-layout with a company mission statement on the left and product-specific details on the right.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/6", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-6", "loopMatches": [ { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 7, "slideType": "timeline", "function": "cite_precedent", "notes": "The slide highlights the lineage of the boron chemistry platform and the transition of assets from Anacor/Pfizer to AN2 Therapeutics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/7", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-7", "loopMatches": [ { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 8, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a timeline-based roadmap structure to communicate clinical trial progress.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/8", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-8", "loopMatches": [ { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 9, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/9", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-9", "loopMatches": [ { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 10, "slideType": "problem_statement", "function": "frame_problem", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/10", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-10", "loopMatches": [ { "to": 12, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "4aa0dbf2-56da-494f-901a-64b26c295698", "evidence": "Slides 10-12 emphasize the unmet medical need", "position": 0, "objective": "Highlight the need for new treatments for NTM lung disease", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 12, "from": 10, "beatId": "15046727-6f68-47c4-9a45-b89d72c286c9", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Slides 10-12 describe the problem of NTM lung disease", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 11, "slideType": "market_sizing", "function": "size_opportunity", "notes": "Uses a Venn/concentric circle diagram to illustrate market segmentation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/11", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-11", "loopMatches": [ { "to": 12, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "4aa0dbf2-56da-494f-901a-64b26c295698", "evidence": "Slides 10-12 emphasize the unmet medical need", "position": 0, "objective": "Highlight the need for new treatments for NTM lung disease", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 12, "from": 10, "beatId": "15046727-6f68-47c4-9a45-b89d72c286c9", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Slides 10-12 describe the problem of NTM lung disease", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" }, { "to": 11, "from": 11, "beatId": "411cb3f4-d879-4121-a8e7-9b3252458882", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "Slide 11 provides market sizing information", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 12, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a process flow to show the progression from treatment-naïve to refractory patients.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/12", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-12", "loopMatches": [ { "to": 12, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "4aa0dbf2-56da-494f-901a-64b26c295698", "evidence": "Slides 10-12 emphasize the unmet medical need", "position": 0, "objective": "Highlight the need for new treatments for NTM lung disease", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 12, "from": 10, "beatId": "15046727-6f68-47c4-9a45-b89d72c286c9", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Slides 10-12 describe the problem of NTM lung disease", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 13, "slideType": "appendix_disclosure", "function": "cite_precedent", "notes": "Includes boxed warning information for a competitor/reference drug.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/13", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-13", "loopMatches": [ { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 14, "slideType": "solution", "function": "present_solution", "notes": "Scientific diagram showing molecular binding interaction.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/14", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-14", "loopMatches": [ { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 15, "from": 14, "beatId": "9abc67ab-1d05-4188-be2d-63e830f35c72", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 14-15 present epetraborole as a solution", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 15, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "MIC = Minimum Inhibitory Concentration. Data shows Epetraborole has lower MIC values compared to standard treatments.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/15", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-15", "loopMatches": [ { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 15, "from": 14, "beatId": "9abc67ab-1d05-4188-be2d-63e830f35c72", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 14-15 present epetraborole as a solution", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" }, { "to": 15, "from": 15, "beatId": "21eb2361-df38-4147-b0d5-9d63628836c7", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Competition", "beatSlug": "sequoia-pitch-competition", "evidence": "Slide 15 shows competitive analysis", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 16, "slideType": "traction", "function": "show_traction", "notes": "The chart highlights statistical significance between EBO doses and the CLR control.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/16", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-16", "loopMatches": [ { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 17, "slideType": "traction", "function": "analyze_data", "notes": "EBO = epetraborole, SoC = standard of care (clarithromycin, ethambutol, rifabutin).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/17", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-17", "loopMatches": [ { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 18, "slideType": "traction", "function": "show_traction", "notes": "Includes a timeline diagram of the study design and key clinical findings.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/18", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-18", "loopMatches": [ { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 19, "slideType": "traction", "function": "show_traction", "notes": "The slide highlights the drug's targeted delivery to the site of infection (alveolar macrophages).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/19", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-19", "loopMatches": [ { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 20, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide outlines a seamless trial design with specific patient counts and milestones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/20", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-20", "loopMatches": [ { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 21, "slideType": "go_to_market", "function": "plan_implementation", "notes": "Uses a concentric circle diagram to represent market segments and a map to show geographic reach.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/21", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-21", "loopMatches": [ { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 22, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The table uses checkmarks and X marks to highlight competitive advantages of EBO.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/22", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-22", "loopMatches": [ { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 23, "slideType": "unfair_advantage", "function": "establish_context", "notes": "QIDP = Qualified Infectious Disease Product Designation", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/23", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-23", "loopMatches": [ { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 24, "slideType": "traction", "function": "show_traction", "notes": "Includes a timeline of clinical trials and a list of key investors.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/24", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-24", "loopMatches": [ { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 25, "slideType": "mission", "function": "inspire_vision", "notes": "The slide highlights a focus on melioidosis and lists key research and funding partners.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/25", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-25", "loopMatches": [ { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 26, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a split-layout with a company mission statement on the left and product details on the right.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/26", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-26", "loopMatches": [ { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-468c-700c-89db-ca818deece7f", "docSlug": "40fd19b5105eee76fe8edee20250e12b", "documentTitle": "AN2 Therapeutics | IPO Presentation Deck | 27 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 27, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-468c-700c-89db-ca818deece7f/27", "deckHref": "/decks/019de072-468c-700c-89db-ca818deece7f", "deckAnchorHref": "/decks/019de072-468c-700c-89db-ca818deece7f#slide-27", "loopMatches": [ { "to": 27, "from": 1, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "5c43fe0e-f0f3-4ff4-8709-c2c99c61b351", "evidence": "The deck starts and ends with the company's mission", "position": 1, "objective": "Present a clear mission and vision for AN2 Therapeutics", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-4729-7396-8f8e-eb3955e66e61", "docSlug": "7286daabf487d40c2a70ede12061c49a", "documentTitle": "Apexigen | SPAC Presentation Deck | 28 slides", "authorId": "apexigen", "authorName": "Apexigen", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/5e4EXcxxCzAFcYtLuv-jtrWW8BpuMKXP-ZFQQ4leYAE/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83Mjg2ZGFhYmY0ODdkNDBjMmE3MGVkZTEyMDYxYzQ5YS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-4729-7396-8f8e-eb3955e66e61/1", "deckHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61", "deckAnchorHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/ZR3xeyCU5z8-KcmYQ4kehVb77xlcJQjyV8V7DO8GsFM/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83Mjg2ZGFhYmY0ODdkNDBjMmE3MGVkZTEyMDYxYzQ5YS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/12wCkvpFsjEPlvLosz7SpmYM1COqPeVX5KSY41F2qeA/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83Mjg2ZGFhYmY0ODdkNDBjMmE3MGVkZTEyMDYxYzQ5YS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/dwZqu4UWNZ5iclwj1CWtZYEyIuOEJj-TvmbsJ_B5SxQ/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83Mjg2ZGFhYmY0ODdkNDBjMmE3MGVkZTEyMDYxYzQ5YS9wMDAxLnBuZw" }, { "docId": "019de072-4729-7396-8f8e-eb3955e66e61", "docSlug": "7286daabf487d40c2a70ede12061c49a", "documentTitle": "Apexigen | SPAC Presentation Deck | 28 slides", "authorId": "apexigen", "authorName": "Apexigen", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-4729-7396-8f8e-eb3955e66e61/2", "deckHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61", "deckAnchorHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-4729-7396-8f8e-eb3955e66e61", "docSlug": "7286daabf487d40c2a70ede12061c49a", "documentTitle": "Apexigen | SPAC Presentation Deck | 28 slides", "authorId": "apexigen", "authorName": "Apexigen", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "context", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-4729-7396-8f8e-eb3955e66e61/3", "deckHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61", "deckAnchorHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-4729-7396-8f8e-eb3955e66e61", "docSlug": "7286daabf487d40c2a70ede12061c49a", "documentTitle": "Apexigen | SPAC Presentation Deck | 28 slides", "authorId": "apexigen", "authorName": "Apexigen", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes footnote regarding transaction expenses and equity line exclusion.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-4729-7396-8f8e-eb3955e66e61/4", "deckHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61", "deckAnchorHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-4729-7396-8f8e-eb3955e66e61", "docSlug": "7286daabf487d40c2a70ede12061c49a", "documentTitle": "Apexigen | SPAC Presentation Deck | 28 slides", "authorId": "apexigen", "authorName": "Apexigen", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes detailed footnotes regarding share calculations, redemption assumptions, and transaction costs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-4729-7396-8f8e-eb3955e66e61/5", "deckHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61", "deckAnchorHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-4729-7396-8f8e-eb3955e66e61", "docSlug": "7286daabf487d40c2a70ede12061c49a", "documentTitle": "Apexigen | SPAC Presentation Deck | 28 slides", "authorId": "apexigen", "authorName": "Apexigen", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "team_bio", "function": "other", "notes": "The slide uses a table-like layout to associate team members with their past company affiliations and a separate column for investor logos.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-4729-7396-8f8e-eb3955e66e61/6", "deckHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61", "deckAnchorHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 6, "from": 6, "beatId": "981ae9cc-c507-41e8-9bc5-6d6c983bc4b0", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "The management team is presented with deep expertise and seasoned investors.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-4729-7396-8f8e-eb3955e66e61", "docSlug": "7286daabf487d40c2a70ede12061c49a", "documentTitle": "Apexigen | SPAC Presentation Deck | 28 slides", "authorId": "apexigen", "authorName": "Apexigen", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a three-column layout for key business pillars supported by a central platform foundation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-4729-7396-8f8e-eb3955e66e61/7", "deckHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61", "deckAnchorHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61#slide-7", "loopMatches": [ { "to": 7, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "398acacc-ee0a-4473-8f0c-104232e4369b", "evidence": "The executive summary emphasizes the importance of addressing cancer.", "position": 0, "objective": "Highlight the need for innovative cancer treatments", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 7, "from": 7, "beatId": "ecbe4e76-7700-4b1c-9c52-a7802f904770", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The executive summary highlights the need for innovative therapeutic antibodies against cancer.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-4729-7396-8f8e-eb3955e66e61", "docSlug": "7286daabf487d40c2a70ede12061c49a", "documentTitle": "Apexigen | SPAC Presentation Deck | 28 slides", "authorId": "apexigen", "authorName": "Apexigen", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a Gantt-style visualization to represent drug development progress across various therapeutic areas.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-4729-7396-8f8e-eb3955e66e61/8", "deckHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61", "deckAnchorHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 8, "beatId": "07553f5d-001d-4161-b6fb-9f265d1e67ac", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "The roadmap section implies a large market opportunity for cancer treatment.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-4729-7396-8f8e-eb3955e66e61", "docSlug": "7286daabf487d40c2a70ede12061c49a", "documentTitle": "Apexigen | SPAC Presentation Deck | 28 slides", "authorId": "apexigen", "authorName": "Apexigen", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "transition", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-4729-7396-8f8e-eb3955e66e61/9", "deckHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61", "deckAnchorHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61#slide-9", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-4729-7396-8f8e-eb3955e66e61", "docSlug": "7286daabf487d40c2a70ede12061c49a", "documentTitle": "Apexigen | SPAC Presentation Deck | 28 slides", "authorId": "apexigen", "authorName": "Apexigen", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a biological pathway diagram to illustrate the mechanism of action.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-4729-7396-8f8e-eb3955e66e61/10", "deckHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61", "deckAnchorHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61#slide-10", "loopMatches": [ { "to": 11, "from": 10, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3eb55c6a-aa43-4de6-9bf7-e2573f2f45ff", "evidence": "The deck describes Sotigalimab's mechanism of action and potential advantages.", "position": 1, "objective": "Explain how Sotigalimab works and its potential benefits", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 11, "from": 10, "beatId": "cf2ade2d-f00f-40fa-8a0f-9569a750612a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The deck presents Sotigalimab as a potential first-in-class CD40 agonist antibody and describes the APXiMAB platform.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" }, { "to": 15, "from": 10, "beatId": "eabcce46-c7fe-4e05-b519-ae0aa88c80cb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "The deck provides details on Sotigalimab's clinical development program and potential applications.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-4729-7396-8f8e-eb3955e66e61", "docSlug": "7286daabf487d40c2a70ede12061c49a", "documentTitle": "Apexigen | SPAC Presentation Deck | 28 slides", "authorId": "apexigen", "authorName": "Apexigen", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "solution", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-4729-7396-8f8e-eb3955e66e61/11", "deckHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61", "deckAnchorHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61#slide-11", "loopMatches": [ { "to": 11, "from": 10, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3eb55c6a-aa43-4de6-9bf7-e2573f2f45ff", "evidence": "The deck describes Sotigalimab's mechanism of action and potential advantages.", "position": 1, "objective": "Explain how Sotigalimab works and its potential benefits", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 11, "from": 10, "beatId": "cf2ade2d-f00f-40fa-8a0f-9569a750612a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The deck presents Sotigalimab as a potential first-in-class CD40 agonist antibody and describes the APXiMAB platform.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" }, { "to": 15, "from": 10, "beatId": "eabcce46-c7fe-4e05-b519-ae0aa88c80cb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "The deck provides details on Sotigalimab's clinical development program and potential applications.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-4729-7396-8f8e-eb3955e66e61", "docSlug": "7286daabf487d40c2a70ede12061c49a", "documentTitle": "Apexigen | SPAC Presentation Deck | 28 slides", "authorId": "apexigen", "authorName": "Apexigen", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a funnel diagram to represent the clinical development strategy, emphasizing learning and de-risking.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-4729-7396-8f8e-eb3955e66e61/12", "deckHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61", "deckAnchorHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 10, "beatId": "eabcce46-c7fe-4e05-b519-ae0aa88c80cb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "The deck provides details on Sotigalimab's clinical development program and potential applications.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-4729-7396-8f8e-eb3955e66e61", "docSlug": "7286daabf487d40c2a70ede12061c49a", "documentTitle": "Apexigen | SPAC Presentation Deck | 28 slides", "authorId": "apexigen", "authorName": "Apexigen", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "traction", "function": "show_traction", "notes": "The slide highlights a 'Single MoA Focus' on the right, emphasizing the mechanism of action for the combination therapies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-4729-7396-8f8e-eb3955e66e61/13", "deckHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61", "deckAnchorHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 10, "beatId": "eabcce46-c7fe-4e05-b519-ae0aa88c80cb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "The deck provides details on Sotigalimab's clinical development program and potential applications.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-4729-7396-8f8e-eb3955e66e61", "docSlug": "7286daabf487d40c2a70ede12061c49a", "documentTitle": "Apexigen | SPAC Presentation Deck | 28 slides", "authorId": "apexigen", "authorName": "Apexigen", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "traction", "function": "show_traction", "notes": "The slide uses two waterfall/spider plots to demonstrate efficacy in different clinical settings.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-4729-7396-8f8e-eb3955e66e61/14", "deckHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61", "deckAnchorHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 10, "beatId": "eabcce46-c7fe-4e05-b519-ae0aa88c80cb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "The deck provides details on Sotigalimab's clinical development program and potential applications.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-4729-7396-8f8e-eb3955e66e61", "docSlug": "7286daabf487d40c2a70ede12061c49a", "documentTitle": "Apexigen | SPAC Presentation Deck | 28 slides", "authorId": "apexigen", "authorName": "Apexigen", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "traction", "function": "show_traction", "notes": "Includes study design, interim efficacy data, and a Kaplan-Meier survival curve comparison.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-4729-7396-8f8e-eb3955e66e61/15", "deckHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61", "deckAnchorHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 10, "beatId": "eabcce46-c7fe-4e05-b519-ae0aa88c80cb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "The deck provides details on Sotigalimab's clinical development program and potential applications.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-4729-7396-8f8e-eb3955e66e61", "docSlug": "7286daabf487d40c2a70ede12061c49a", "documentTitle": "Apexigen | SPAC Presentation Deck | 28 slides", "authorId": "apexigen", "authorName": "Apexigen", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "traction", "function": "show_traction", "notes": "Includes study design flowchart, spider plot of tumor size changes, and summary statistics of patient responses.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-4729-7396-8f8e-eb3955e66e61/16", "deckHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61", "deckAnchorHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-4729-7396-8f8e-eb3955e66e61", "docSlug": "7286daabf487d40c2a70ede12061c49a", "documentTitle": "Apexigen | SPAC Presentation Deck | 28 slides", "authorId": "apexigen", "authorName": "Apexigen", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "appendix_data", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-4729-7396-8f8e-eb3955e66e61/17", "deckHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61", "deckAnchorHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-4729-7396-8f8e-eb3955e66e61", "docSlug": "7286daabf487d40c2a70ede12061c49a", "documentTitle": "Apexigen | SPAC Presentation Deck | 28 slides", "authorId": "apexigen", "authorName": "Apexigen", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-4729-7396-8f8e-eb3955e66e61/18", "deckHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61", "deckAnchorHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-4729-7396-8f8e-eb3955e66e61", "docSlug": "7286daabf487d40c2a70ede12061c49a", "documentTitle": "Apexigen | SPAC Presentation Deck | 28 slides", "authorId": "apexigen", "authorName": "Apexigen", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-4729-7396-8f8e-eb3955e66e61/19", "deckHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61", "deckAnchorHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-4729-7396-8f8e-eb3955e66e61", "docSlug": "7286daabf487d40c2a70ede12061c49a", "documentTitle": "Apexigen | SPAC Presentation Deck | 28 slides", "authorId": "apexigen", "authorName": "Apexigen", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a biological process diagram to illustrate the mechanism of action.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-4729-7396-8f8e-eb3955e66e61/20", "deckHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61", "deckAnchorHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }